Sponsor or institution
Clinical trials and research at Agios Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Agios Pharmaceuticals, Inc. that are recruiting, at sites in 2 countries (most in United States (4), Poland (1)). By phase: Phase 3 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Mitapivat for reducing transfusion needs in sickle cell disease | Phase 3 | Indianapolis, Indiana and 4 other locations | Recruiting | Jun 18, 2026 |
| Mitapivat for pediatric non-transfusion-dependent alpha- or beta-thalassemia | Phase 3 | Palo Alto, California and 4 other locations | Recruiting | Apr 8, 2026 |
| Mitapivat for pediatric transfusion-dependent thalassemia (α- or β-TDT) | Phase 3 | Atlanta, Georgia and 3 other locations | Recruiting | Apr 2, 2026 |
| AG-181 safety and tolerability in people with phenylketonuria | Phase 1 | Indianapolis, Indiana and 4 other locations | Recruiting | Nov 21, 2025 |
All recruiting trials (4)
-
Mitapivat for reducing transfusion needs in sickle cell disease
This study tests whether mitapivat, compared with placebo, can lower the number of blood transfusions needed by people with sickle cell disease.
-
Mitapivat for pediatric non-transfusion-dependent alpha- or beta-thalassemia
This study tests whether mitapivat helps reduce anemia in children with non-transfusion-dependent alpha- or beta-thalassemia compared with placebo.
-
Mitapivat for pediatric transfusion-dependent thalassemia (α- or β-TDT)
This pediatric trial tests whether mitapivat can reduce or lessen the need for transfusions in children with transfusion-dependent alpha- or beta-thalassemia.
-
AG-181 safety and tolerability in people with phenylketonuria
This trial will test AG-181 for safety and tolerability in people with PKU who have high blood phenylalanine and at least one R408W PAH mutation.
Quick answers
How many clinical trials run by Agios Pharmaceuticals, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.